LUCISANO, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 291
EU - Europa 98
AS - Asia 42
AF - Africa 7
OC - Oceania 1
Totale 439
Nazione #
US - Stati Uniti d'America 289
IT - Italia 65
SG - Singapore 17
IN - India 13
SE - Svezia 12
BG - Bulgaria 6
TG - Togo 5
CN - Cina 4
GB - Regno Unito 4
TW - Taiwan 4
IR - Iran 3
PL - Polonia 3
CA - Canada 2
DE - Germania 2
EG - Egitto 2
FI - Finlandia 2
AU - Australia 1
GR - Grecia 1
IE - Irlanda 1
NL - Olanda 1
TR - Turchia 1
UA - Ucraina 1
Totale 439
Città #
Fairfield 50
Woodbridge 26
Cambridge 25
Wilmington 24
Seattle 21
Chandler 20
Rome 20
Ashburn 16
Houston 13
Singapore 13
Princeton 8
San Paolo di Civitate 8
Ann Arbor 7
Sofia 6
Lawrence 5
Lomé 5
Milan 5
Millbury 4
Naples 4
Taipei 4
Andover 3
Boston 3
Plano 3
San Diego 3
Warsaw 3
Beijing 2
Calcio 2
Catania 2
Fasano 2
Giza 2
Kish 2
New York 2
Portici 2
Santa Clara 2
Venezia 2
Athens 1
Benevento 1
Bremen 1
Cleveland 1
Dearborn 1
Dublin 1
Essendon 1
Fremont 1
Grottaglie 1
Helsinki 1
Le Casine-Perignano-Spinelli 1
London 1
Lucca 1
Newark 1
Norwalk 1
Ottawa 1
Pomezia 1
Redwood City 1
Shenyang 1
Stockholm 1
Torino 1
Toronto 1
Wandsworth 1
Washington 1
Totale 343
Nome #
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT). A randomised, multicentre trial 145
Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis 100
Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factors 54
Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies 46
Arsenic exposure and risk of urothelial cancer. Systematic review and meta-analysis 45
null 33
Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS Register 30
Prognostic indicators in pediatric clinically isolated syndrome 21
Evaluation of drivers of treatment switch in relapsing multiple sclerosis. A study from the Italian MS Registry 17
ANGPTL3 Deficiency and Risk of Hepatic Steatosis 11
null 3
Totale 505
Categoria #
all - tutte 1.419
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.419


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202054 0 0 3 1 6 7 7 7 7 5 5 6
2020/202194 8 4 0 0 1 2 16 3 3 42 9 6
2021/202284 11 8 6 0 14 7 0 8 8 4 9 9
2022/202391 15 21 5 6 12 5 1 6 11 1 2 6
2023/202482 2 6 4 9 2 11 7 3 3 15 8 12
2024/202525 8 11 6 0 0 0 0 0 0 0 0 0
Totale 505